Condition

Anesthesia (1)

Diffuse Large B Cell Lymphoma (1)

Diffuse Large B-Cell Lymphoma (1)

Follicular Lymphoma Grade 3B (1)

High-grade B-cell Lymphoma (1)

Peripheral Venous Catheterization (1)

Transformed B-Cell Lymphoma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Not yet recruiting (1)

Terminated (1)

Phase

n/a (2)

phase 1 (1)

phase 2 (1)

Sponsor

Ataturk University (1)

Cedars-Sinai Medical Center (1)

MedImmune LLC (1)

Washington University School of Medicine (1)

Collaborator

Genentech, Inc. (1)

Study Documents

Intervention Type

drug (4)

other (2)

combination product (1)

device (1)

procedure (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (4)

ice

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Peripheral Venous Catheterization Trial in Erzurum, Gumushane (drug, combination product, other)

Active, not recruiting

Peripheral Venous Catheterization

Jet lidocaine
+2 more

Erzurum, Centre, Turkey
+1 more

Dec 13, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma Trial in Saint Louis (Mosunetuzumab,

Not yet recruiting

Diffuse Large B Cell Lymphoma
+3 more

Mosunetuzumab
+2 more

Saint Louis, Missouri

Washington University School of Medicine

Jul 14, 2022

Anesthesia Trial (drug, other, device)

Terminated

Has Results

Anesthesia

Marcaine
+3 more

(no location specified)

Aug 8, 2018

DLBCL Trial in Worldwide (MEDI-551 2 mg/kg, Rituximab, ICE)

Completed

Has Results

Diffuse Large B-Cell Lymphoma

MEDI-551 2 mg/kg
+5 more

Birmingham, Alabama
+82 more

Feb 8, 2018